Related Experiment Video

Updated: May 11, 2026

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)
06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)

Published on: April 7, 2021

Acute respiratory distress syndrome in children: physiology and management

David N Cornfield1

  • 1Division of Pediatric Critical Care Medicine, Department of Pediatrics, Center for Excellence in Pulmonary Biology, Lucile Packard Children's Hospital, Stanford University School of Medicine, Stanford, California, USA. cornfield@stanford.edu

Current Opinion in Pediatrics
|May 10, 2013
PubMed

Insights

Acute Respiratory Distress Syndrome (ARDS) in children is a serious condition. Optimizing treatment through understanding its pathophysiology and employing lung-protective ventilation strategies improves survival and minimizes lung injury.

Area of Science:

  • Pediatric critical care medicine
  • Respiratory physiology
  • Neonatology

Background:

  • Acute Respiratory Distress Syndrome (ARDS) is a significant cause of mortality and morbidity in pediatric populations.
  • Risk factors for ARDS in children include trauma, pneumonia, aspiration, and immune compromise.
  • Understanding the underlying pathophysiologic processes is crucial for effective management.

Purpose of the Study:

  • To review the pathophysiologic mechanisms of ARDS development in children.
  • To provide a physiologic basis for optimizing ARDS treatment strategies in pediatric patients.
  • To enhance clinical outcomes for children with ARDS.

Main Methods:

  • Literature review focusing on pediatric ARDS pathophysiology and treatment.
  • Analysis of current evidence regarding ventilation strategies and adjunctive therapies.
  • Synthesis of physiologic principles guiding ARDS management.

Main Results:

  • An open-lung ventilation strategy is associated with improved survival and reduced lung injury.
  • Key components of lung-protective ventilation include adequate positive end-expiratory pressure (PEEP), limited tidal volume (5-7 cc/kg), and low plateau pressure (≤30 cmH2O).
  • The relative benefits of high-frequency oscillatory ventilation, surfactant replacement, and inhaled nitric oxide are discussed.

Conclusions:

  • ARDS continues to be a critical challenge in pediatric care, contributing to significant mortality and morbidity.
  • Application of established physiologic principles in clinical practice can optimize patient outcomes.
  • Effective management hinges on understanding ARDS pathophysiology and implementing lung-protective ventilation.
Abstract

More Related Videos

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...